Regulatory insights on advanced CAR-T cell products, AAV-based Gene therapies, and medical care/practice in cell and Gene therapies: Report from the 6th Asia partnership conference of regenerative medicine- April 20, 2023.

Regen Ther · 2024 · PMC11550569 · PMID 39524180

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

A notable trend was that large pharmaceutical companies, such as Pfizer, Novartis, and Roche, have been developing AAV gene therapies, mainly in Japan, South Korea, and Taiwan.

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.